POST Online Media Lite Edition


Veracyte appoints Rob Brainin as executive vice president

Christian Fernsby |
San Francisco, Ca., USA - Veracyte, a genomic diagnostics company, announced that Rob Brainin will join the company as executive vice president and chief business officer.

Article continues below

Mr. Brainin brings more than 20 years of executive experience in life sciences and health care.

Mr. Brainin most recently served as chief executive officer of Genuity Science (formerly known as WuXi NextCode), a company focused on integrating clinical and molecular data to derive insights that accelerate drug discovery and development.

Prior to that, he served as vice president and general manager of the Life Sciences and Applied Genomics Business at Illumina, Inc. and, before that, was vice president and general manager of the Enterprise Genomics Solutions business of Thermo Fisher Scientific, Inc.

Prior to that, Mr. Brainin served in a number of positions at Life Technologies, Inc. and its predecessor, Invitrogen, primarily leading large businesses that served customers in the academic, clinical and biopharmaceutical segments.

Earlier in his career, he was a management consultant at McKinsey & Co. and has served as an adjunct professor at the University of San Diego School of Law.

Mr. Brainin is a member of the board of directors of Champions Oncology and the Children’s Tumor Foundation.